Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 18:07:52 - browse：965

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Large hospital system sues Multiplan for low

WSS

The history of OxyContin, told through Purdue Pharma documents

Canadians with cystic fibrosis outlive Americans by a decade

Maui funeral service workers on devastation of fires: 'I'm in shock'

'Screen and refer' systems are hurting patients

Covid's long

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Drug repurposing or repositioning? The language matters

'Screen and refer' systems are hurting patients

In age of alternative facts, a scholarly course on calling out crap

CDC overhauls leadership of center that led response to Covid

Continuity nursing helped my family in our darkest PICU moments

Kim Kardashian sparks debate on benefits of full

Duchenne breakthrough therapy leaves behind pioneering families

Some of the ways extreme heat will change life as we know it

United colonoscopy coverage change 'may cost lives,' doctors say

Vertex cell therapy lets patients with type 1 diabetes stop insulin

leisure time

'Screen and refer' systems are hurting patients

Beware reading your test results before your doctor does

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Faced with fears of OxyContin misuse, sales reps touted its safety

What affirmative action's end means to a medical student

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

leisure time

knowledge

explore

focus